ID18964A - Garam-garam dimesilat dari ligan-ligan neuropeptida y - Google Patents

Garam-garam dimesilat dari ligan-ligan neuropeptida y

Info

Publication number
ID18964A
ID18964A IDP973762A ID973762A ID18964A ID 18964 A ID18964 A ID 18964A ID P973762 A IDP973762 A ID P973762A ID 973762 A ID973762 A ID 973762A ID 18964 A ID18964 A ID 18964A
Authority
ID
Indonesia
Prior art keywords
neuropeptidal
ligans
sales
salt
salt sales
Prior art date
Application number
IDP973762A
Other languages
English (en)
Indonesian (id)
Inventor
Douglas J M Allen
Lyle R Brostrom
Alireza S Kord
Laurie A Whipple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID18964A publication Critical patent/ID18964A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP973762A 1996-11-26 1997-11-25 Garam-garam dimesilat dari ligan-ligan neuropeptida y ID18964A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
ID18964A true ID18964A (id) 1998-05-28

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP973762A ID18964A (id) 1996-11-26 1997-11-25 Garam-garam dimesilat dari ligan-ligan neuropeptida y

Country Status (23)

Country Link
US (1) US5914329A (enExample)
EP (1) EP0944611B1 (enExample)
JP (1) JP3120861B2 (enExample)
AP (1) AP9701148A0 (enExample)
AR (1) AR010304A1 (enExample)
AT (1) ATE257472T1 (enExample)
AU (1) AU4792497A (enExample)
BR (1) BR9713538A (enExample)
CA (1) CA2272927C (enExample)
DE (1) DE69727155T2 (enExample)
DK (1) DK0944611T3 (enExample)
ES (1) ES2213207T3 (enExample)
GT (1) GT199700123A (enExample)
HN (1) HN1997000154A (enExample)
HR (1) HRP970640A2 (enExample)
ID (1) ID18964A (enExample)
MA (1) MA26450A1 (enExample)
PA (1) PA8441701A1 (enExample)
PE (1) PE17099A1 (enExample)
PT (1) PT944611E (enExample)
TN (1) TNSN97191A1 (enExample)
WO (1) WO1998023603A1 (enExample)
ZA (1) ZA9710587B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001232900A1 (en) * 2000-01-20 2001-07-31 Michael Amling Methods and compositions for control of bone formation via modulation of neuropeptide y activity
US20060165683A1 (en) 2001-12-05 2006-07-27 Gerard Karsenty Methods and compositions for control of bone formation via modulation of sympathetic tone
US7273703B2 (en) 2002-01-09 2007-09-25 Funbogen Ab Detection of mutations
EP1814593A4 (en) * 2004-11-23 2012-09-05 Dong Wha Pharm Co Ltd ORAL PREPARATION HAVING IMPROVED BIOAVAILABILITY
AU2006235200A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of Neuropeptide Y (NPY) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ137297A3 (cs) * 1994-11-07 1998-04-15 Pfizer Inc. Substituované benzylaminové deriváty

Also Published As

Publication number Publication date
DE69727155D1 (de) 2004-02-12
ATE257472T1 (de) 2004-01-15
CA2272927A1 (en) 1998-06-04
JP3120861B2 (ja) 2000-12-25
CA2272927C (en) 2003-02-04
MA26450A1 (fr) 2004-12-20
HRP970640A2 (en) 1998-10-31
WO1998023603A1 (en) 1998-06-04
DE69727155T2 (de) 2004-07-08
DK0944611T3 (da) 2004-04-13
PE17099A1 (es) 1999-02-19
PA8441701A1 (es) 2000-05-24
AP9701148A0 (en) 1998-01-31
GT199700123A (es) 1999-05-19
TNSN97191A1 (fr) 2005-03-15
AU4792497A (en) 1998-06-22
EP0944611B1 (en) 2004-01-07
HN1997000154A (es) 1999-02-09
ZA9710587B (en) 1999-05-25
AR010304A1 (es) 2000-06-07
BR9713538A (enExample) 2000-03-21
PT944611E (pt) 2004-04-30
ES2213207T3 (es) 2004-08-16
US5914329A (en) 1999-06-22
EP0944611A1 (en) 1999-09-29
JP2000505110A (ja) 2000-04-25

Similar Documents

Publication Publication Date Title
DE69832185D1 (de) Dichroischer polarisator
DE69818442D1 (de) Substituierte 3-cyanochinoline
NO307628B1 (no) Salgsanordning
DE59804697D1 (de) Doppelfilter
ID24829A (id) Garam natrium omeprazola
PT1036083E (pt) Novos 9a-azalidos
DE59813487D1 (de) Substituierte 4-benzoyl-pyrazole
DE69823599D1 (de) Streifenregner
DE59804098D1 (de) Verdampferanordnung
FI954574A7 (fi) Kopolyamidit
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
ID18964A (id) Garam-garam dimesilat dari ligan-ligan neuropeptida y
DE69819010D1 (de) Verbesserter sprinkler
EP0949331A4 (en) Established microglial cells
ATE244705T1 (de) Substituierte 4-benzoyl-pyrazole
DK0908120T3 (da) Reol
DE59807877D1 (de) Substituierte 4-benzoyl-pyrazole
ID24079A (id) Aminoheteroksiklilamida tersubstitusi
DK0827503T3 (da) Pyrrolidinylmethylindol-salt
ATA195097A (de) Korbartiger baustein
DK0862964T3 (da) Svejsebolte
BR9601758A (pt) Saleiro anti-umectante
DE59810960D1 (de) Substituierte phenyluracile
KR970019330U (ko) 상표
IT1296035B1 (it) Spruzza sale